Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles et al. · The Lancet · 2016 · 3.7K citations

Medicine, Oncology, Pharmacotherapy +13

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses

Li Wang, Rotem Rubinstein, J. Louise Lines et al. · The Journal of Experimental Medicine · 2011 · 704 citations · Full text

Life Sciences, Cell Biology, Immunology +17

VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer

Jianjun Gao, John F. Ward, Curtis A. Pettaway et al. · Nature Medicine · 2017 · 592 citations

Life Sciences, Immunology, Oncology +16

VISTA Is an Immune Checkpoint Molecule for Human T Cells

J. Louise Lines, Eirini Pantazi, Justin Mak et al. · Cancer Research · 2014 · 500 citations · Full text

Medicine, Immunology, Oncology +17